Litcius/Paper detail

Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells

Adrià Cañellas‐Socias, Carme Cortina, Xavier Hernando‐Momblona, Sergio Palomo‐Ponce, Eoghan J. Mulholland, Gemma Turón, Lídia Mateo, Sefora Conti, Olga Roman, Marta Sevillano, Felipe Slebe, Diana Stork, Adrià Caballé, Antonio Berenguer, Adrián Álvarez-Varela, Nicola Fenderico, Laura Novellasdemunt, Laura Jiménez-Gracia, Tamara Sipka, Lídia Bardia, Patricia Lorden, Julien Colombelli, Holger Heyn, Xavier Trepat, Sabine Tejpar, Elena Sancho, Daniele V. F. Tauriello, Simon J. Leedham, Camille Stephan‐Otto Attolini, Eduard Batlle

2022Nature235 citationsDOIOpen Access PDF

Topics & Concepts

MedicineColorectal cancerPopulationCancer researchOncologyLGR5DiseaseMinimal residual diseaseInternal medicinePrimary tumorCancerPathologyMetastasisEnvironmental healthLeukemiaCancer Cells and MetastasisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells | Litcius